Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 14, 2015; 21(38): 10840-10852
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10840
Table 1 Univariate and multivariate survival analysis for overall survival and recurrence-free survival in The Cancer Genome Atlas patients with hepatocellular carcinoma
VariablesOverall survival
Recurrence-free survival
Relative risk (95%CI)P valueRelative risk (95%CI)P value
Univariate
Age (> 60 vs ≤ 60 yr)1.17 (0.76-1.80)0.481.33 (0.83-2.14)0.24
Gender (female vs male)1.21 (0.78-1.86)0.390.91 (0.72-1.15)0.44
Differentiation (Poorly vs well and moderately)1.27 (0.83-1.95)0.280.76 (0.48-1.21)0.25
Residual tumor (R1 + R2 vs R0)1.95 (0.94-4.06)0.072.25 (1.02-4.98)0.05
Child-Pugh classification (grade B vs A)2.49 (1.21-5.12)0.012.22 (0.95-5.19)0.07
Vascular invasion (macro + micro vs none)1.52 (0.94-2.46)0.081.65 (1.00-2.71)0.05
TNM staging (III + IV vs I + II)2.39 (1.51-3.79)< 0.0014.32 (2.50-7.47)< 0.001
Fibrosis (fibrosis + cirrhosis vs none)0.98 (0.88-1.08)0.630.81 (0.46-1.41)0.45
AFP (≥ 200 ng/mL vs < 200 ng/mL)1.15 (0.68-1.92)0.610.85 (0.49-1.49)0.58
PRDX1 expression (high vs low)1.55 (1.01-2.36)0.041.01 (0.63-1.60)0.98
Inflammation in adjacent liver (severe + mild vs none)1.20 (0.79-1.80)0.391.30 (0.82-2.07)0.26
Multivariate
Residual tumor (R1 + R2 vs R0)--0. 89 (0.28-2.89)0.77
Child-Pugh classification (grade B vs A)2.30 (1.10-4.78)0.03--
Vascular invasion (macro + micro vs none)--1.42 (0.79-2.55)0.23
TNM staging (III + IV vs I + II)2.36 (1.26-4.41)0.0075.04 (2.76-9.22)< 0.001
PRDX1 expression (high vs low)1.89 (1.07-3.36)0.03--